key: cord-0711337-0xsxy9pr
authors: Katsuta, Tomohiro; Shimizu, Naoki; Okada, Kenji; Tanaka‐Taya, Keiko; Nakano, Takashi; Kamiya, Hajime; Amo, Kiyoko; Ishiwada, Naruhiko; Iwata, Satoshi; Oshiro, Makoto; Okabe, Nobuhiko; Kira, Ryutaro; Korematsu, Seigo; Suga, Shigeru; Tsugawa, Takeshi; Nishimura, Naoko; Hishiki, Haruka; Fujioka, Masashi; Hosoya, Mitsuaki; Mizuno, Yumi; Mine, Mahito; Miyairi, Isao; Miyazaki, Chiaki; Morioka, Ichiro; Morishima, Tsuneo; Yoshikawa, Tetsushi; Wada, Taizo; Azuma, Hiroshi; Kusuhara, Koichi; Ouchi, Kazunobu; Saitoh, Akihiko; Moriuchi, Hiroyuki
title: The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan
date: 2021-07-07
journal: Pediatr Int
DOI: 10.1111/ped.14912
sha: 93b7276cb49401a24b002614ab71a8b86297dc20
doc_id: 711337
cord_uid: 0xsxy9pr

BACKGROUND: Coronavirus disease 2019 (COVID‐19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. METHODS: We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (<16 years old) COVID‐19 cases reported between February and December 2020 in Japan, using a dedicated database that was voluntarily registered by the members of the Japan Pediatric Society. RESULTS: Almost half of patients (47.7%) were asymptomatic, while most of the others presented mild symptoms. At the time of admission or first outpatient clinic visit, 84.0% of the cases were afebrile (<37.5°C). In total, 609 cases (72.5%) were exposed to COVID‐19‐positive household members. We analyzed the influence of nationwide school closures that were introduced in March 2020 on COVID‐19 transmission routes among children in Japan. Transmission within households occurred most frequently, with no significant difference between the periods before and after declaring nationwide school closures (70.9% and 74.5%, respectively). CONCLUSIONS: COVID‐19 symptoms in pediatric cases are less severe than those in adult cases. School closure appeared to be limitedly effective, and controlling household transmission from adult family members is the most important measure for COVID‐19 prevention among children.

Since the beginning of 2020, coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide and become a global threat. Most reports on pediatric COVID-19 cases suggested that children experienced fewer or milder symptoms than adults did. [1] [2] [3] In contrast, there have also been some reports on critically ill pediatric patients. 4, 5 In Japan, despite the large number of asymptomatic COVID-19 patients, who were

This article is protected by copyright. All rights reserved diagnosed using an application-based contact tracing system or cluster survey by health care centers, the number of COVID-19 patients is lower than those in other countries. This study aimed to analyze the epidemiology, clinical manifestations, and outcomes of pediatric COVID-19 in Japan, using a dedicated database in which physicians who were members of the Japan Pediatric Society (JPS) registered voluntarily. This is the first nationwide study that focused on all pediatric COVID-19 cases, including patients with no or mild symptoms, reported by all the pediatricians in Japan.

We included pediatric patients aged <20 years old who were diagnosed with COVID-19 by real-time reverse transcriptase polymerase chain reaction (PCR) or loop-mediated isothermal amplification (LAMP) tests, conducted at the local health center or commercial laboratories. Although we started our study in May 2020, the first pediatric COVID-19 case in Japan had already been reported in February 2020.

Hence, the study period was from February to December 2020, and some of the

This article is protected by copyright. All rights reserved cases were registered retrospectively. This registry was based on the COVID-19 case report form that was established by the World Health Organization and International Severe Acute Respiratory and Emerging Infection Consortium. 6 Physicians input the patient's data into the dedicated database including epidemiological characteristics, clinical symptoms and signs and laboratory findings at the first hospital or clinic visit, treatment, hospitalization status, complications, and prognosis at the time of discharge from the hospital. We defined asymptomatic cases as those with positive SARS-CoV-2 PCR or LAMP test results "without any clinical symptoms of acute respiratory infection including fever, cough, dyspnea, or tachypnea at any time throughout the course." In asymptomatic cases, we assumed that the date of onset was when the test result was confirmed. The results obtained from the database were automatically presented as charts (e.g., graphs), by the dedicated software, swiftly published on the JPS website, and updated daily. 7 Initially, 907 laboratory-confirmed pediatric COVID-19 cases (patients aged <20 years old) were reported. As of December 29, 2020, which almost coincided with the end of our study period, there were 18,605 confirmed COVID-19 cases among patients aged <20 years old in Japan. 8 We excluded all

This article is protected by copyright. All rights reserved patients aged between 16-19 years old from this study because we assumed that most patients in this age group visit internists rather than pediatricians. Ultimately, 840 pediatric COVID-19 patients aged <16 years old were included in this study.

In Japan, nationwide school closures were introduced in March 2020. Thereafter, some children, mainly living in large cities, were prohibited from attending school until August 31 st ,2020 when the summer vacation ended. Most schools resumed regular schedule in September. Hence, we divided the study periods into prereopen period (from February to August 2020) and post-reopen period (from September to December 2020). The source of infection with SARS-CoV-2 was compared between the respective study periods.

Statistical analysis was performed using the statistical analysis software R version 3.6.2 (R Foundation for Statistical Computing, Vienna, Austria), and statistical significance (p<0.05) was assessed using Fisher's exact test.

This study was approved by the Ethics Review Committee of the JPS (approval number: 32).

This article is protected by copyright. All rights reserved

National emergency was declared on April 7 in 7 urban prefectures including Tokyo, which became nationwide on April 16. Since then, pediatric cases were reported daily with two peak periods.

In total, 4.9% (907/18,605) of the nationwide pediatric COVID-19 cases aged <20 years old in Japan were registered in this database. Finally, 840 pediatric COVID-19 patients who were <16 years old were enrolled during the study period ( Table 1 ).

The median age was 6 years (interquartile range [IQR]: 2-11). Among them, 440 cases (52.4%) were males. Almost a half of the patients in this study were asymptomatic ( Figure 1 ). Nevertheless, during the study period, Japanese government recommended hospitalization to all COVID-19 patients for monitoring and quarantine even if their symptom was not severe, and the hospitalization threshold for COVID-19 patients in Japan was extremely low. As a result, among the 840 cases, 709 (84.4%) were hospitalized, including four patients who were

This article is protected by copyright. All rights reserved admitted to the intensive care unit (ICU) (Figure 2 , Table 4 ). The admission rates among patients aged <1, 1-5, 6-10, and 11-15 years were 92.4%, 80.1%, 80.4%, and 90.3%, respectively. The average length of hospital stay was 9.3±5.2 days.

Most of the pediatric patients had mild clinical symptoms, and 401 (47.9%) were asymptomatic ( Table 2 ). At the time of admission or the first outpatient clinic visit, only 130 patients (16.0%) had fever (≥37.5°C). Other vital signs, including the heart rate, respiratory rate, and oxygen saturation on room air, were within normal ranges in 90% of cases. Additionally, only 300 patients (35.8%) had a history of fever at any time during the clinical course. The common symptoms at the onset of the illness were runny nose and dry cough (194 and 166; 23.1% and 19.8%, respectively). Forty-two (median age: 12 years (range 5-16 years)) and 33 (median age: 13 years (range 6-16 years)) patients had dysgeusia and dysosmia, respectively.

This article is protected by copyright. All rights reserved Few patients had leucopenia with neutropenia and lymphopenia (14.0%, 4.5%, and 2.6%, respectively) ( Table 3 ). The levels of most inflammatory markers, interleukin-6, liver enzymes, biochemical markers of myocardial damage, and the coagulation function markers were within the normal ranges.

Chest X-ray and computed tomography (CT) scans were examined in 316 and 85 cases, respectively; 92.4% and 80.0% of them had normal results, respectively ( Table 3 ). The most frequently recognized abnormal CT findings were ground-glass opacities (GGOs) and consolidation; eight cases (9.4%) had either or both.

Antiviral drugs were not administered to any of the patients (Table 4 ). Inhaled (ciclesonide), intravenous, and oral steroids were administered to one (0.1%), five (0.6%), and one (0.1%) of the patients, respectively. As supportive care, oxygen therapy was administered to 11 cases. Invasive ventilation, inotropes/vasopressors, and placement in the prone position were introduced to a single infantile case.

Neither extracorporeal membrane oxygenation (ECMO) support, renal replacement therapy (RRT) nor dialysis was used in this study population.

This article is protected by copyright. All rights reserved

Ten (1.3%) and five (0.6%) cases were clinically diagnosed as pneumonia and bronchitis, respectively (Table 5 ). Shock and cardiac arrhythmias were confirmed in a single case. Encephalopathy and cardiac arrest were confirmed in another single case. There was no fatal case in this study.

Among all 840 pediatric cases aged <16 years old, 778 cases (92.6%) had recent contact with a SARS-CoV-2-positive person ( Table 6) . Of the total, 609 cases (72.5%) were exposed to infected household members. The most frequent index case in the family was father (31.8%). SARS-CoV-2 was transmitted less frequently from siblings in the household (2.6%) or members of the same school (6.2%), kindergarten/nursery (6.2%), and private tutoring school (0.9%). Among the 449 patients that were infected with SARS-CoV-2 during the nationwide school closures and summer vacation period, who were categorized into the pre-reopen period group, 318 (70.9%) contracted it from their family members, especially adults. Of the 391 patients in the post-reopen period group, 291 (74.5%) contracted it from family members. The transmission rate from mothers increased significantly from

This article is protected by copyright. All rights reserved 18.3% in pre-reopen period to 25.6% in post-reopen period (p<0.05). While transmission rate at school increased from 4.2% in pre-reopen period to 8.4% in post-reopen period (p<0.05). Contrarily, the transmission rate from members of the same kindergarten/nursery decreased significantly from 9.8% to 2.0% (p<0.05).

This is the first nationwide study of pediatric COVID-19 based on pediatricians' report of all SARS-CoV-2 positive cases under the condition that the comprehensive PCR examinations were carried out by the public health centers as a cluster survey for people who had close contact with any COVID-19 patient, regardless of their clinical symptoms.

Japan has been amid the third peak epidemic period, which is larger than the preceding two, since the third week in November 2020. 8 Limiting the statistics to pediatric cases, however, the third epidemic peak was yet to be confirmed as of December 2020.

This article is protected by copyright. All rights reserved

Notably, almost half of the patients in this study were asymptomatic throughout the course. In Japan, public health centers conduct an extensive retrospective contact tracing of COVID-19 patients and comprehensive PCR tests of the people who had close contact with them. Thus, we assumed that many asymptomatic COVID-19 cases, including pediatric cases, were confirmed through this nationwide study.

In this study, patients aged <1 year old had the highest hospitalization rate (91.6%). A previous study suggested that young children, particularly infants, are vulnerable to infection. 2, 9 However, there was no simple way to evaluate the difference in COVID-19 severity by hospitalization rate because COVID-19 patients, especially younger patients, are generally recommended to be hospitalized for observation and quarantine in Japan, even though they were asymptomatic or mildly symptomatic.

Although underlying health conditions, including chronic respiratory diseases, obesity, and neurological diseases, were common in hospitalized pediatric COVID-

This article is protected by copyright. All rights reserved 19 patients, 1, 10, 11 it is unclear whether these conditions influenced the severity and actual hospitalization rate among the children in this study because only a few of them had underlying health conditions. A previous study suggested that existing chronic condition is independently associated with severe COVID-19 in children. 12 Multinational systematic reviews reported that 15-60% of pediatric COVID-19 cases were asymptomatic, 13 and the most commonly described symptoms in the pediatric age group were fever, cough, and sore throat (51.6%, 47.3%, and 17.9%, respectively). 1 In this study, almost half of our cases (47.9%) were asymptomatic.

In addition, vital signs were also generally stable at the first hospital or clinical visit, and 84% of them were afebrile (<37.5°C). These results suggest that body temperature measurement is not sensitive to screen pediatric COVID-19 cases. In this study, other clinical symptoms in children were also less common than those reported in the previous reviews; even the most frequent symptoms such as runny nose and cough were present in only approximately 20% of the cases in this study.

This article is protected by copyright. All rights reserved

In this study, similar to a previous review, 1 some patients experienced extrarespiratory symptoms such as diarrhea, headache, fatigue/malaise, dysgeusia, dysosmia, and vomiting. In particular, dysgeusia and dysosmia have been recognized as unusual symptoms that have a high likelihood of being related to COVID-19. However, both are reported less commonly in children. 14,15 Studies

have not yet clarified why the clinical symptoms in most pediatric COVID-19 cases are mild. Previous reports hypothesized that children are less sensitive to SARS-CoV-2 because the maturity and function of angiotensin-converting enzyme 2, the receptor that SARS-CoV-2 uses for host cellular entry, may be lower than those in adults. 2, 16 Multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS), a severe inflammatory complication resembling Kawasaki disease, has been reported among African and Hispanic children in Europe and North America. [17] [18] [19] [20] In Japan, as of December 2020, only one case of Kawasaki disease following COVID-19 was reported; however, it did not meet the diagnostic criteria for MIS-C/PIMS and improved with no coronary artery lesion. 21

This article is protected by copyright. All rights reserved Subsequently, as of June 2021, some suspected cases of MIS-C/PIMS were reported in Japan. [22] [23] [24] The mechanism of the epidemiological and clinical differences related to MIS-C/PIMS among children from different racial/ethnic background globally has not been clarified yet.

Lymphopenia had been found in 31-40% of pediatric COVID-19 cases, 9, 25 and in approximately 80% of critically ill adult cases. 26 Contrarily, similar to the findings in other previous surveys, 27,28 abnormalities in the laboratory tests, such as the lymphocyte count and levels of inflammatory markers, cytokines, liver enzymes, biochemical markers of myocardial damage, and coagulation function markers, have been less frequently observed in this study.

Such a difference in laboratory test abnormalities may be explained by the difference in the COVID-19 severity found in our study population.

Previous studies have suggested that chest radiography might range from normal findings to the sign of severe acute respiratory distress syndrome type appearance 29 and might fail to identify mild pediatric COVID-19 cases without

This article is protected by copyright. All rights reserved significant clinical symptoms. 1, 30 In this study, 92.4% of the pediatric COVID-19 cases had normal chest X-ray findings. Some previous studies reported that the most common CT finding was bilateral GGOs, which was detected in 30-60% of the pediatric cases. 3, 30 However, routine CT scans in the pediatric setting increases unnecessary exposure to radiation. In this study, only 85 cases (10.1%) underwent CT scans, and most of them (68 cases; 80.0%) had normal findings. This is also consistent with the hypothesis that we included more mild or asymptomatic cases, due to the study design, than other studies did.

In this study, 709 cases (84.4%) were hospitalized, which was much higher than the percentages of hospitalized children <18 years of age in the United States (US) (5.7%). 31 As mentioned earlier, this result reflects the fact that most pediatric cases in Japan were hospitalized for quarantine and observation, even though they had no or mild clinical symptoms. However, medical resources are limited due to the increase in the number of cases among the elderly. Further discussion is required to determine the conditions for COVID-19 childhood admission.

This article is protected by copyright. All rights reserved

We could not evaluate the efficacy of antiviral drugs because no child case was administered antiviral drugs in this study. The Pediatric Infectious Diseases Society guidelines suggest that antiviral therapy for COVID-19 is not necessary for the majority of pediatric patients. 32

A multinational systematic review reported that severe and critically ill COVID-19 cases accounted for 2% and 0.6% of the total pediatric cases, respectively. 1 In this study, no fatal case was reported. Although four cases (0.5%) required ICU admissions, only one of them required invasive ventilation, and none of them required more aggressive supportive care such as ECMO, RRT, or dialysis. These data are consistent with those of the previous studies, which reported that most pediatric COVID-19 cases are not severe. In addition, as of December 2020, there was no confirmed MIS-C/PIMS case in this study. Although the exact reason has not yet been clarified, MIS-C/PIMS has been reportedly rare in Asian countries, 33 compared with the US and European countries.

This article is protected by copyright. All rights reserved Previous studies reported that SARS-CoV-2 transmission to children mainly involves household contact, and adult family members are the most common primary source of infection. 1, 3, 13, [34] [35] [36] Similarly, 72.5% of the cases in this study contracted the infection through household contact, most of which were adult-to-child transmission.

During the early period of COVID-19 pandemic, many countries implemented national school closures, despite the lack of data on the relative contribution of school closures to transmission control. A previous study reported that school closure was temporally associated with decreased COVID-19 incidence and mortality. 37 However, another study reported that school closures alone would prevent only 2-4% of the deaths, 38 which much lower than that for other social distancing interventions, and that school closures alone hardly changed the epidemic curve. 39 Instead, some reviews have noted the disadvantages of school closures, including economic damage to working parents; loss of education; negative effect on child welfare, particularly among the most vulnerable pupils; and nutritional problems, especially in children for whom free school meals are an important source of nutrition. 38, 40 In Japan, nationwide school closures were also

This article is protected by copyright. All rights reserved implemented in March 2020, and most children had difficulty attending school until the normal school schedule was resumed in September 2020. Household transmission rates were similar between the pre-and post-reopen periods (70.9% and 74.5%, respectively). Although the transmission rate at school was significantly higher (33 cases, 8.4%) in post-reopen period than that in the prereopen period (19 cases, 4.2%) (p<0.05), 16 cases (4.1%) contracted SARS-CoV-2 from adults (e.g., teachers). Child-to-child transmission among schoolmates occurred in 12 cases (2.7%) during the pre-reopen period and in 15 cases (3.8%) during the post-reopen period, and the difference was not statistically significant.

These results suggest that SARS-CoV-2 transmission to children is mainly from family members, regardless of whether school is open or closed. Using an agestructured mathematical model, Davies et al. found that there was limited effectiveness in school closures. 41 Some academia including the JPS, American Academy of Pediatrics advocated that opening schools does not significantly increase SARS-CoV-2 transmission in the community in general. 42, 43 The reason why the transmission rate from mothers increased significantly between pre-reopen period and post-reopen period is unknown. However,

This article is protected by copyright. All rights reserved regarding all COVID-19 cases in Japan, the ratio of female COVID-19 cases in prereopen period (male : female = 1.3 : 1 as of August 5th, 2020) 44 was lower than that of post-reopen period (male : female = 1.1 : 1 as of December 29th, 2020) 8 ."

This study had a few limitations. First, we were unable to assess the secondary infection rate from the reported pediatric cases, including transmission to family members, friends, and teachers. Second, only 4.9% of the nationwide pediatric cases in Japan were included in this study. We have been considering simplifying the survey content to improve the response rate. Third, each condition or complication including pneumonia, bronchitis, shock, encephalopathy, and acute respiratory distress syndrome were not clearly defined during the survey. These judgements were done by each physician, so that there might be a bias for diagnosing the condition or complication depending upon reported physicians.

Fourth, recently, COVID-19 due to new variants has been reported worldwide.

However, no cases due to new variants have been reported during the period of this study in Japan, and we could not evaluate the influence of such variants of SARS-CoV-2. Finally, it was difficult to generalize the results from this study that included more mild or asymptomatic cases.

This article is protected by copyright. All rights reserved including ribavirin, lopinavir/ritonavir, neuraminidase inhibitor, favipiravir, remdesivir, interferon-α, and interferon-β. ‡ All 5 cases had started to use inhaled steroids before they were infected. with COVID-19. 

SARS-COV-2 infection in children and newborns: a systematic review

Epidemiology of COVID-19 Among Children in China

SARS-CoV-2 Infection in Children

Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with Coronavirus Disease

Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris

International Severe Acute Respiratory and Emerging Infection Consortium

Information about epidemiology and clinical manifestation about pediatric COVID-19 cases in Japan using a national database

Accepted Article This article is protected by copyright. All rights reserved 8. Ministry of Health Labour and Welfare. Epidemiology of COVID-19 in Japan

Clinical Characteristics of Children with Coronavirus Disease

Coronavirus Disease 2019 Case Surveillance -United States

Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units

Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19

Role of children in the transmission of the COVID-19 pandemic: a rapid scoping review

Early Experience of COVID-19 in a US Children's Hospital

A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children

Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults

Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Multisystem Inflammatory Syndrome in Children in New York State

COVID-19 and multisystem inflammatory syndrome in children and adolescents. The Lancet Infectious Diseases

A case of multisystem inflammatory syndrome in children in a japanese boy: with discussion of cytokine profile

Multisystem Inflammatory Syndrome in Children-A New Syndrome Complicated With Acute Heart Failure Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Multisystem inflammatory syndrome associated with SARS-CoV-2 in a Japanese girl

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical characteristics of COVID-19 in children compared with adults in Shandong Province

Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients

Pediatric radiologic manifestations of COVID-19

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults

CDC Covid-Response Team. Coronavirus Disease 2019 in Children -United States

Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea. Emerg Infect Dis

Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis

COVID-19 in Children and the Dynamics of Infection in Families

A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features

Association of the Timing of School Closings and Behavioral Changes With the Evolution of the Coronavirus Disease

School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review

Impact of Social Distancing Measures on Coronavirus Disease Healthcare Demand

School closure during novel influenza: A systematic review

Age-dependent effects in the transmission and control of COVID-19 epidemics

COVID-19 Guidance for Safe Schools

Pre-reopen period

Adult cases (teachers, nurses

Children had a few opportunities to meet with their friends even pre-reopen period because not all schools, kindergartens and nurseries had closed completely

We thank all Japan Pediatric Society members who participated in this study.

Conflicts of interest: All authors have no reported conflicts.

Research Grants from the Ministry of Health, Labour and Welfare in Japan.

This article is protected by copyright. All rights reserved